Oaktree Acquisition Corp. III Life Sciences (OACCU) Cash & Equivalents (2025)

Oaktree Acquisition Corp. III Life Sciences (OACCU) reported Cash & Equivalents of $1.4 million for Q2 2025, up 8.11% quarter-over-quarter from $1.3 million in Q1 2025.

Oaktree Acquisition Corp. III Life Sciences (OACCU) Cash & Equivalents (2025) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported Cash & Equivalents for 1 years, with the latest figure at $1.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - 1.47 Mn
2 Berto Acquisition 312.16 Mn 312.16 Mn - 209,016.00
3 Centurion Acquisition 311.79 Mn 311.79 Mn - 28,828.00
4 Churchill Capital Corp IX 309.64 Mn 309.64 Mn - 167,798.00
5 WEN Acquisition 308.55 Mn 308.55 Mn - 553,972.00
6 Agriculture & Natural Solutions Acquisition 304.08 Mn 304.08 Mn - 1.00
7 Bold Eagle Acquisition 274.25 Mn 274.25 Mn - 521,352.00
8 Soulpower Acquisition 265.17 Mn 265.17 Mn - 56,403.00
9 BTC Development 263.21 Mn 263.21 Mn - 1.45 Mn
10 Oaktree Acquisition Corp. III Life Sciences - - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 1.39 Mn
Mar 31, 2025 1.28 Mn